GasgonMedical_Crest_Wht_2019.png

#infusedwithconfidence

 

In the News...
 

Results of H2020 funding published by EU Commission

November 23, 2020

Medicine’s bubble trouble popped by innovative valve; An article has been published on the 'Results in Brief' section of the European Commission's CORDIS website, detailing our use of grant support from the EC Horizon 2020 Phase 1 to discover exciting new areas of impact for our technology. It can be read here...

Collaborating to improve patient outcomes

July 31, 2020

Gasgon Medical is honoured to be working with the clinical team at Centro Hospitalar e Universitário de Coimbra  (CHUC), a leading institute for healthcare in Portugal. Our project, SAFE-Infusion,  has been selected by CHUC to further their commitment to improving patient safety and healthcare performance. We will work closely together to identify opportunities to deliver better outcomes and ensure patients across Portugal continue to be offered the best healthcare treatments, with safety and quality at the core.

Ready for ACTION in Boston

September 30, 2020

Gasgon Medical was recently selected for the InterACTION program, one of just 5 companies from an international cohort (Israel, Spain, India, US, Ireland). With a particular focus on Boston and the surrounding New England region as a market entry location, this program delivered mentoring and focused insights from leading domain experts including; FDA regulatory pathway, legal frameworks, investment and sales strategy. Gasgon was selected alongside other leading medical product companies looking to expand our international network and fast track entry to the US market.

InterACTION Healthcare 2020 program is an initiative by ACTION Innovation Network. ACTION Innovation Network (“ACTION”) is an association of technology innovation centers that represent an established community of committed partners from industry, academics, private sector, and government in the Boston/greater Boston area.

Working together to increase occupational safety

August 31, 2020

Gasgon is excited to announce a joint collaboration project with Tada Medical, a Sweden-based developer of novel IV components, to improve safety of IV infusions for patients and care providers. Recently a joint poster was accepted for display at the European Oncology Nurses Society (EONS) annual congress, in conjunction with European Society for Medical Oncology (ESMO). This project examines how the shifting of IV therapy from the hospital to the home will pose a challenge with regards to risk management. Two of the most important safety issues are identified to be the risk of vascular air embolism and IV line dislodgement. Exposure to hazardous drugs is a leading cause of harm for nurses, a problem which will continue into the home. Through our collaboration, both Gasgon and Tada will continue working to improve safety of hazardous drug infusions for patients, nurses and care providers across all settings.

Gasgon; Accelerated by EIC Phase 1

August 18, 2020

As part of the EIC SME Instrument Phase 1 Feasibility Grant (No. 887764) Gasgon Medical has undertaken commercial and technical feasibility activities to determine the practical applications for its novel technology in the healthcare marketplace. Through collaboration with clinicians and hospitals across Europe, Gasgon has identified a broad range of areas that would benefit from its proprietary technology, including Paediatrics, Cardiology, Intensive and Oncology. As a result of this support from EIC, Gasgon Medical has developed key clinical and technical partnerships to rapidly pursue the commercial potential. On the level of H2020 priorities, this project and its outcomes will address “Health, demographic change and wellbeing” by improving IV therapy safety in-hospital and at home, benefiting EU taxpayers and patients.

Collaborating to deliver better patient outcomes

May 30, 2020

We are very proud to be working with the great team at Fundació Sant Joan de Déu (FSJD), a leading Barcelona ​research foundation, to prepare our IV infusion devices for launch. The clinical team at P​arc Sanitari Sant Joan de Déu (PSSJD), ​the healthcare campus linked to FSJD, is committed to improving safety and clinical outcomes for their patients, and have identified strong potential in Gasgon's technology. We will continue to investigate opportunities to develop devices that improve IV fluid management together as part of our commitment to improving patient care and clinical safety.

Gasgon: Supporting nurses in Europe and beyond

March 01, 2020

Gasgon Medical was delighted to meet with Paul De Raeve, Secretary General of the European Federation of Nurses in Brussels, to discuss the important role EFN carries out advocating strongly for its 3 million nurse members across the EU, as well as the wider role MedTech innovation can play to reduce the burden of care at the bedside. We look forward to continuing to work closely with EFN to support our amazing nurses.

Gasgon selected for funding under EIC’s SME Instrument Phase 1

January 01, 2020

Gasgon Medical has been selected by European Commission for funding and acceleration as part of the final SME Instrument Phase 1. Out of 3,299 entries, just 283 projects across 31 European countries have been selected for funding in this final round. A great boost for Gasgon Medical as we launch our medical products to improve IV fluid therapy for patients worldwide.

Gasgon awarded 2nd place overall at European Health Catapult Finals

December 02, 2019

So proud that Gasgon Medical was awarded 2nd place overall in MedTech category of the prestigious EIT Health European Health Catapult in Paris, the biggest competition for Medtech, Biotech and Digitalhealth start-ups in Europe. With over 200 incredible start-ups from all over the continent competing, validation at this level from leading healthcare investors and stakeholders highlights the exciting future ahead for Gasgon Medical as we launch new technologies to improve the way IV fluid medicine is administered for patients globally.

EIT Health European Health Catapult semifinals

June 23, 2019

Gasgon Medical is excited to be selected in the top 14 European MedTech companies to compete at the prestigious EIT Health European Health Catapult semifinals, taking place in San Sebastian, Spain. The European Health Catapult, which has been called one of the top competitions for biotech start-ups in Europe, is designed to identify and accelerate promising European start-ups in the categories of biotech, medtech and digital health.

Gasgon Medical awarded Seal of Excellence by European Commission

March 31, 2019

Gasgon Medical is proud to be recognised by a panel of independent international experts in the highly competitive SME Instrument evaluation process. This award supports our ambitions to bring important new medical devices to market and further validates our business plans, particularly in the areas of excellence, impact, quality and efficiency of implementation. Holders of the Seal of Excellence are invited as members to the Access4SMEs community, which aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors.


The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not receive funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.

5 innovative European sci-tech startups you should know about in 2019

March 03, 2019

Gasgon Medical was featured among Silicon Canal's article, entitled " 5 innovative European sci-tech startups you should know about in 2019 "

CEO Gasgon Medical presents at European Life Sciences CEO Forum in Zurich

February 26, 2019

On February 25-26th, Gasgon Medical attended the Sachs 12th Annual European Life Sciences CEO Forum (ELSCEO), in Zurich, Switzerland, presenting on-stage during the Rising Stars: Start-up Show Case Session.

EIT Health selected Gasgon Medical as one of only five startup companies from across Europe to showcase its innovative business, providing full support for the two-day event which included seminar panels, one-to-one meetings and networking activities.

 

The event was attended by investors and corporate leaders from powerhouse companies in the LifeScience sector, with a focus on scaling opportunities in biotech, therapeutics, medtech, and digital health. CEO of Gasgon Medical, Vincent Forde, presented our exciting technology that is overcoming the challenge of managing gas bubbles that cause harm, including stroke and heart attack, during common IV infusions.

EIT Health Headstart Competition 2018

June 25, 2018

Gasgon Medical is honoured to be recognised as one of the top 10 Medtech startups in UK & Ireland, winning €50,000 funding and supports from EIT Health Headstart Funding Programme 2018. The finals took place in Liverpool, with 20 teams from all over the UK and Ireland completing a 2 day bootcamp before competing for prizes. The funding enables further development of our devices, with supports including mentoring and Living Labs from across Europe provided by EIT Health.

Gasgon Medical wins in Boston

April 22, 2018

At the finals, taking place in Boston, Gasgon Medical was chosen as one of two top Irish startups to be fast-tracked into MassChallenge's global accelerator, to take place later this year. From a competitive group of MedTech and LifeScience startups chosen from across Ireland, Gasgon Medical and Cortechs Connect were selected as leading projects and offered the chance to return to Boston for final pitching, with an opportunity to participate in the highly prestigious MassChallenge cohort of 2018.

MassChallenge Boston

February 21, 2018

Gasgon Medical was recently selected to travel to Boston as one of the twelve Irish MedTech and LifeScience startups, chosen from a national campaign run by Cork County Council...

Gasgon Medical wins in Copenhagen at the University Startup World Cup

November 01, 2017

Gasgon Medical was in Copenhagen recently, selected to represent Ireland at the Venture Cup University Startup World Cup, supported by Cork Institute of Technology. Vincent and Conor spent one week in bootcamp before the final pitching took place in Copenhagen's Institute of Technology. Gasgon was competing with winning entries from 55 countries internationally and successfully came home with the 'HealthTech Leadership Award'...

Gasgon Medical wins at Ireland's Best Young Entrepreneur

January 17, 2017

Gasgon won IBYE’s Best New Idea category from LEO South Cork and the title of ‘Best Young Entrepreneur’ for the South Cork region. The business also received €7,000 investment, supported by the Local Enterprise Office in South Cork...

Gasgon Medical recognised at the Early Career Awards

November 30, 2016

Gasgon Medical was awarded the top award in the 'Special Recognition' category at the glittering black tie event in Dublin's Mansion House...

Gasgon Medical wins National College Entrepreneur of the Year title

October 03, 2016

Vincent Forde, a student from CIT, has today won the Enterprise Ireland Student Entrepreneur of the Year Award and been named ‘College Entrepreneur of the Year 2016’ for the island of Ireland...

Gasgon Medical success at CIT Prize for Innovation

March 27, 2016

Innovative CIT student Vincent Forde has won CIT Entrepreneur of the Year 2016...

Leaders of Tomorrow award for Gasgon Medical

March 02, 2016

Gasgon Medical wins its first award, taking home the prestigious Accenture 'Leaders of Tomorrow' title...

Please reload

© 2020 | Gasgon Medical